Blog Post
Resilience in Life Sciences Infrastructure
Uninterrupted operations are essential in today’s pharmaceutical manufacturing environment. Facilities must deliver consistent output without sacrificing quality, even amid complex infrastructure demands, global supply pressures,...
Read More
Blog Post
Engaging Early: FDA’s Collaborative Pathways for AI in Regulatory Applications (Part 3 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read More